The prognostic significance of lymphovascular space invasion in laparoscopic versus abdominal hysterectomy for endometrioid endometrial cancer

Introduction: Recent reports have suggested that uterine manipulators can induce lymphovascular space involvement (LVSI) by endometrial cancer in laparoscopic hysterectomy specimens. The prognostic significance of this phenomenon known as “vascular pseudo invasion” remains elusive. Materials and Methods: The authors conducted a retrospective, single institution study of patients who underwent initial surgery for grade 1 and grade 2 endometrioid endometrial cancers with LVSI. Cases were stratified by surgical approach (laparoscopy vs laparotomy). Clinicopathologic and procedure characteristics as well as outcome data were analyzed. Univariate and multivariate analyses were performed. Disease-free survival (DFS) was analyzed using the Kaplan-Meier product limit method. Results: A total of 104 cases (20 laparoscopic, 84 laparotomy) were analyzed. Mean age (65 vs 64 years, respectively), stage distribution, mean number of lymph nodes sampled (18 vs 21, respectively) and use of adjuvant therapy was similar for both groups (p > 0.05). Mean body mass index (BMI) was 30 vs 35 kg/m2, respectively (p = 0.002). Mean follow up was 24 months (range 0.1–102). Univariate analysis demonstrated that LVSI in the laparoscopic setting was associated with worse DFS (p = 0.002). After adjusting for grade the risk of recurrence remained higher for laparoscopic cases (HR: 15.7, 95% CI 1.7–140.0, p = 0.014). Conclusions: Adjusted risk of recurrence associated with LVSI is higher in cases approached laparoscopically arguing against the concept of “vascular pseudo invasion” associated with the use of uterine manipulators and balloons. LVSI should be regarded as a serious risk factor and taken into account for triage to adjuvant therapies, even in laparoscopically treated early-stage endometrial cancer.

Endometrial cancer; Lymphovascular space invasion; Pseudo invasion.

[1] Eltabbakh G.H., Shamonki M.I., Moody J.M., Garafano L.L.: “Laparoscopy as the primary modality for the treatment of women with endometrial carcinoma”. Cancer, 2001, 91, 378.

[2] Malur S., Possover M., Michels W., Schneider A.: “Laparoscopic-assisted vaginal versus abdominal surgery in patients with endometrial cancer - A prospective randomized trial”. Gynecol. Oncol., 2001, 80, 239.

[3] Tozzi R., Malur S., Koehler C., Schneider A.: “Laparoscopy versus laparotomy in endometrial cancer: first analysis of survival of a ran-domized prospective study”. J. Minim. Invasive Gynecol., 2005, 12, 130.

[4] Walker J.L., Piedmonte M.R., Spirtos N.M., Eisenkop S.M., Schlaerth J.B., Mannel R.S., Spiegel G., Barakat R., Pearl M.L., Sharma S.K.: “Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: gynecologic oncology group study LAP2”. J. Clin. Oncol., 2009, 27, 5331.

[5] Logani S., Herdman A.V., Little J.V., Moller K.A.: “Vascular “pseudoinvasion” in laparoscopic hysterectomy specimens: A diag-nostic pitfall”. Am. J. Surg. Pathol., 2008, 32, 560.

[6] Kitahara S., Walsh C., Frumovitz M., Malpica A., Silva E.G.: “Vascular pseudoinvasion in laparoscopic hysterectomy specimens for endometrial cancer: A grossing artifact?”. Am. J. Surg. Pathol., 2009, 33, 298.

[7] Folkins A.K., Nevadunsky N.S., Saleemuddin A., Jarboe E.A., Muto M.G., Feltmate C.M., Crum C.P., Hirsch M.S.: “Evaluation of vascular space involvement in endometrial adenocarcinomas: laparoscopic vs abdominal hysterectomies”. Mod. Pathol., 2010, 23, 1073.

[8] Krizova A., Clarke B.A., Bernardini M.Q., James S., Kalloger S.E., Boerner S.L., Mulligan A.M.: “Histologic artifacts in abdominal, vaginal, laparoscopic and robotic hysterectomy specimens: a blinded, retrospective review”. Am. J. Surg. Pathol., 2011, 35, 115.

[9] Keys H.M., Roberts J.A., Brunetto V.L., Zaino R.J., Spirtos N.M., Bloss J.D., Pearlman A., Maiman M.A., Bell J.G.: “Gynecologic Oncology Group. A phase III trial of surgery with or without adjuvant external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a gynecologic oncology group”. Gynecol. Oncol., 2004, 92, 744.

[10] Creasman W.T., Morrow C.P., Bundy B.N., Homesley H.D., Graham J.E., Heller P.B.: “Surgical pathologic spread patterns of endometrial cancer: A Gynecologic Oncology Group Study”. Cancer, 1987, 60, 2035.

[11] Guntupalli S.R., Zighelboim I., Kizer N.T., Zhang Q., Powell M. A., Thaker P.H., Goodfellow P.J., Mutch D.G.: “Lymphovascular space invasion is an independent risk factor for nodal disease and poor outcomes in endometrioid endometrial cancer”. Gynecol. Oncol., 2011, Oct 24 [Epub ahead of print].

[12] Nofech-Mozes S., Ackerman I., Ghorab Z. et al.: “Lymphovascular invasion is a significant predictor for distant recurrence in patients with early-stage endometrial endometrioid adenocarci-noma”. Am. J. Clin. Pathol., 2008, 129, 912.